Unexplained weight loss (UWL) is a frequent clinical challenge for physicians. It is often associated with underlying serious conditions, including malignancies, gastrointestinal disorders, and endocrine abnormalities. This article aims to provide a comprehensive approach to the evaluation and management of UWL in clinical practice.
UWL can be a manifestation of multiple pathologies. The most common causes include malignancies, chronic infections, gastrointestinal disorders, and endocrine abnormalities. The pathophysiology of UWL is multifactorial and often involves a combination of reduced caloric intake, increased metabolic rate, and malabsorption.
A thorough history and physical examination are essential in the assessment of UWL. The history should focus on the duration of weight loss, associated symptoms, and risk factors for specific diseases. Physical examination should include a comprehensive systemic evaluation to identify any signs of underlying disease.
The diagnostic approach to UWL should be guided by the clinical assessment. Initial investigations may include a complete blood count, metabolic panel, thyroid function tests, and imaging studies. Further investigations should be directed by the initial findings and may include endoscopy, biopsy, or specialized imaging studies.
Management of UWL is primarily directed towards treating the underlying cause. Nutritional support and symptom management are also important aspects of patient care. Early diagnosis and treatment can significantly improve patient outcomes.
UWL is a complex clinical problem that requires a systematic and comprehensive approach. A thorough history, physical examination, and appropriate investigations are crucial in identifying the underlying cause. Timely diagnosis and management can significantly improve patient outcomes and quality of life.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation